Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Bryn Pressnail"'
Publikováno v:
Hematology. 23:596-599
Patients with a single hematological malignancy may be unexpectedly diagnosed with a clonally unrelated synchronous dual hematological malignancy (SDHM). The presence of a secondary hematological malignancy may be overlooked and only identified in si
Autor:
Bryn Pressnail, Ari M. Vanderwalde, Nancy L. Bartlett, Mitchell R. Smith, Paul G. Montgomery, Jonathan W. Friedberg, Ann S. LaCasce, Tricia Ellis, Anthony J. Dodds, Peter Martin, Jeff Szer, Richard van der Jagt, Saurabh Rajguru, Michael D. Williams, Zhengming Chen, Michael Bar, Kristen N. Ganjoo, Katherine Sue Robinson, Fernando Cabanillas, John P. Leonard, Robin Joyce, Jordan A. Herst, Bruce D. Cheson, Bernard Lemieux
Publikováno v:
British Journal of Haematology. 178:250-256
Summary Despite the long history of bendamustine as treatment for indolent non-Hodgkin lymphoma, long-term efficacy and toxicity data are minimal. We reviewed long-term data from three clinical trials to characterize the toxicity and efficacy of pati
Autor:
Yvette Matyas, Bryn Pressnail, Lisa Barbera, Liying Zhang, Joyce Nyhof-Young, Elizabeth Barnes, Cyril Danjoux, Ewa Szumacher, Tracey Keighley-Clarke
Publikováno v:
Canadian Journal of Medical Radiation Technology. 38:7-16
Introduction The Simcoe-Muskoka region of Ontario, Canada, is underserviced with respect to radiotherapy utilization. A group from the Toronto Sunnybrook Regional Cancer Centre and the Royal Victoria Hospital (RVH) of Barrie, Ontario, conducted a stu
Publikováno v:
Blood. 128:5975-5975
Background: Patients with a single hematological malignancy (SHM) may be unexpectedly diagnosed with a synchronous dual hematological malignancy (SDHM). Management of such patients is challenging and the impact of therapy on the secondary malignancy
Autor:
Garth Nicholas, Nevin Murray, Desiree Hao, John Nemunaitis, Yvon Cormier, Francis Nugent, Bryn Pressnail, Rachel E. Sanborn, Christopher Lee, Mark Vincent, Martin E. Gleave, Joe Stephenson, Barbara J. Gitlitz, Janessa Laskin, Yee Ung
Publikováno v:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 7(3)
Purpose Clusterin (CLU), an antiapoptotic, stress-associated protein, confers resistance to therapy when overexpressed. This trial tested custirsen (OGX-011), an inhibitor of CLU protein production, combined with gemcitabine/platinum in patients with
Autor:
Richard I. Aviv, Emily Sinclair, Amanda Hird, Shaelyn Culleton, Bryn Pressnail, Philiz Goh, Edward Chow, Sean P. Symons, Farhad Pirouzmand, Juan M. Bilbao, Sarah Campos, Eric deSa, Philip Davey
Publikováno v:
Current Oncology
Volume 16
Issue 1
Pages 308-66
Scopus-Elsevier
Volume 16
Issue 1
Pages 308-66
Scopus-Elsevier
Brain metastasis is increasingly common, affecting 20%&ndash
40% of cancer patients. After diagnosis, survival is usually limited to months in these patients. Treatment for brain metastasis includes whole-brain radiation therapy, surgical resect
40% of cancer patients. After diagnosis, survival is usually limited to months in these patients. Treatment for brain metastasis includes whole-brain radiation therapy, surgical resect
Autor:
Jonathan W. Friedberg, Ann S. LaCasce, Peter Martin, Anthony J. Dodds, Mitchell R. Smith, Michael Bar, Ari M. Vander Walde, Tricia Ellis, Saurabh Rajguru, Jordan A. Herst, Kristen N. Ganjoo, Richard van der Jagt, Zhengming Chen, Michael E. Williams, Paul G. Montgomery, Bryn Pressnail, Katherine Sue Robinson, Nancy L. Bartlett, Bruce D. Cheson, Fernando Cabanillas, Bernard Lemieux, Robin Joyce, Jeff Szer, John P. Leonard
Publikováno v:
Blood. 126:3961-3961
Background Given the widespread use of bendamustine, data on long-term outcomes are essential for patients and clinicians to understand potential risks and benefits of therapy. Despite a long history as treatment for indolent non-Hodgkin lymphoma (iN
Autor:
Jean-François Pouliot, Teresa M. Petrella, Richard Tozer, Andre Galarneau, Bryn Pressnail, Michael Smylie, G. Knight, Caroline M. Hamm, Tina Cheng, Jose Chang, Nancy Gregorio, Sudhashree Rajagopal
Publikováno v:
Journal of Clinical Oncology. 32:e20038-e20038
e20038^ Background: Melanoma incidence increased dramatically in the last decades. Intron A is the only adjuvant therapy shown to significantly increase progression-free and overall survival in hig...
Autor:
Kotchetkov, Rouslan1 kotchetkovr@rvh.on.ca, Ellison, Erin2, McLean, Jesse3, Pressnail, Bryn1, Nay, Derek1
Publikováno v:
Hematology. Oct2018, Vol. 23 Issue 9, p596-599. 4p.
Autor:
Martin, Peter, Chen, Zhengming, Cheson, Bruce D., Robinson, Katherine S., Williams, Michael, Rajguru, Saurabh A., Friedberg, Jonathan W., Jagt, Richard H., LaCasce, Ann S., Joyce, Robin, Ganjoo, Kristen N., Bartlett, Nancy L., Lemieux, Bernard, VanderWalde, Ari, Herst, Jordan, Szer, Jeffrey, Bar, Michael H., Cabanillas, Fernando, Dodds, Anthony J., Montgomery, Paul G.
Publikováno v:
British Journal of Haematology; Jul2017, Vol. 178 Issue 2, p250-256, 7p